Over the course of my career, I’ve been privileged to serve in roles that blend scientific discovery, corporate leadership, and global health impact. From developing the first anti-TNF inhibitor to founding multiple biotech companies and leading critical medical research in the U.S. Navy, my work has always centered on advancing therapies that change lives. I’m excited to share a detailed look at my professional journey, values, and vision for the future. Here is my biography.

Private equity is undergoing a transformation from its traditional “buy, improve, sell” model into a multifaceted, innovation-driven force. Today’s top firms are diversifying beyond classic acquisitions, incorporating venture capital, real estate, and creative financing to keep and grow strong companies longer. They’re harnessing AI, operational improvements, and sector-specific expertise to drive efficiency and resilience, while targeting future-proof industries like clean energy and healthcare tech. This evolution is also opening access to a wider pool of investors, prioritizing talent as a key growth driver, and navigating political and regulatory shifts with agility. The result is a new era in which private equity acts not just as financier, but as strategic partner, builder, and problem-solver—poised to deliver both stronger returns and more sustainable businesses.

Over the course of my career, I’ve been fortunate to serve in leadership roles across finance, healthcare, fintech, and private equity—both in corporate settings and as an entrepreneur. I’ve led operations, built companies, and partnered with communities to drive meaningful impact. Here is my biography.

After years of partnering with exceptional companies and individuals to align talent with vision, I’m excited to share a deeper look at my journey. This biography highlights my passion for executive search, leadership coaching, and empowering others to thrive in both career and life. Thank you to everyone who has been a part of the story so far.

After more than five decades in finance and leadership—spanning startups, growth-stage companies, and Fortune 500 firms—I’m proud to share my executive biography. My career has been grounded in integrity, strategy, and a passion for building value across the technology sector. I’m excited about new opportunities to serve on boards and advise emerging leaders. Here is my biography.

I'm excited to share a bit more about my professional journey and the value I aim to bring to businesses and boards alike. With over three decades of experience in corporate finance, venture capital, real estate, and compliance, I’ve had the opportunity to help many companies grow with strategic legal guidance. Here is my biography.

After more than 25 years leading companies across the U.S. and Europe—from startups to $800M+ enterprises—I’ve found the next stage of my journey deeply fulfilling: helping others scale with confidence, clarity, and impact. As a founder, board leader, and now advisor, I’m passionate about guiding CEOs, executive teams, and boards through moments of growth and transformation. Here is my biography.

I'm honored to share my executive biography, which reflects the journey I've taken across life sciences, strategic finance, and organizational leadership. My goal has always been to create value at the intersection of innovation and strategy, whether in research, investment, or governance. Here is my biography.

Benjamin A. Jagoe is a distinguished financial executive and investment strategist known for his cross-sector expertise, global investment fluency, and principled leadership. As Chief Investment Officer at Dobbs Management Service, Ben oversees a sophisticated portfolio spanning public equity, private assets, and alternatives—executing strategic acquisitions and advising family stakeholders with institutional-grade rigor. His legacy includes driving operational excellence across six board seats, spearheading venture investment initiatives, and serving as a trusted voice on financial strategy, family governance, and philanthropic engagement.

Dr. Trudy Vanhove is a seasoned biopharmaceutical executive and venture partner with nearly 30 years of experience leading drug development, regulatory strategy, and corporate growth across biotech and pharmaceutical companies. She has played a pivotal role in launching multiple FDA- and EMA-approved therapies and has a strong track record in building high-performing teams, driving strategic partnerships, and supporting financing efforts. Fluent in several languages and with extensive international experience, Dr. Vanhove brings a unique global perspective and a deep scientific and business acumen to board roles and investment opportunities in the biotech sector.

I’m proud to share a snapshot of my professional journey, spanning three decades of business leadership, philanthropy, and international diplomacy. From growing a multi-location restaurant enterprise to advising global stakeholders and launching impactful nonprofits, I remain passionate about purpose-driven work that bridges communities and creates lasting value. Here is my biography.

I'm excited to share a deeper look into my journey across finance, wellness innovation, and strategic leadership. From global engagements to affordable housing advocacy, my passion lies in driving purposeful growth while empowering people and organizations alike. Here is my biography.

I'm a talent acquisition leader passionate about building world-class teams that drive growth and innovation. Over the years, I’ve had the privilege of partnering with high-growth tech companies and global enterprises, leading recruitment strategies across sales, G&A, and executive functions. From scaling teams at Dynatrace during its $1B revenue milestone to collaborating with VC-backed startups at Strive, I thrive on aligning talent with mission-driven goals. I’m committed to mentorship, operational excellence, and creating inclusive, high-performing workplaces where people and businesses succeed together.

Zack Zimmerman is a bold, mission-driven executive whose career has been defined by building and scaling visionary enterprises at the convergence of sustainability, technology,...

John Patrick Kelly is a visionary executive and LegalTech pioneer with over 35 years of leadership experience driving innovation at the intersection of technology, legal services, and investment strategy. As the founder of multiple successful ventures—including KL Capital and BlackStone Discovery—he has consistently delivered transformative results by aligning market insight, operational rigor, and scalable business models. With a strong foundation in legal operations, digital transformation, and venture capital, John is known for his strategic clarity, disciplined execution, and ability to lead high-performing teams through complex, cross-border initiatives. His work has earned him recognition as a trusted advisor to Fortune 500 companies, investors, and boards alike.

Cyril Morel is an accomplished executive whose career spans over 15 years at the intersection of real estate development, financial strategy, and global operations. As Principal and COO of Synapse Development, he has led over $250 million in assets under management, championing energy-efficient projects and pioneering technology-integrated real estate models. Known for his disciplined leadership and strategic decision-making, Cyril has delivered transformative outcomes across multiple sectors—from Passive House-certified multifamily developments in New York to LEED-certified hospitality projects in San Francisco. With a foundation built at the United Nations and refined through ventures in finance and proptech, he brings a rare blend of operational precision, global awareness, and impact-driven vision to every opportunity he pursues.